Microbiota, a New Playground for the Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Diseases

Overview

Journal Mar Drugs

Publisher MDPI

Specialties Biology
Pharmacology

Date 2021 Jan 27

PMID 33498729

Citations 8

Authors

Guy Rousseau

Affiliations

Soon will be listed here.

Abstract

Several cardioprotective mechanisms attributed to Omega-3 polyunsaturated fatty acids (PUFAs) have been studied and widely documented. However, in recent years, studies have supported the concept that the intestinal microbiota can play a much larger role than we had anticipated. Microbiota could contribute to several pathologies, including cardiovascular diseases. Indeed, an imbalance in the microbiota has often been reported in patients with cardiovascular disease and produces low-level inflammation. This inflammation contributes to, more or less, long-term development of cardiovascular diseases. It can also worsen the symptoms and the consequences of these pathologies. According to some studies, omega-3 PUFAs in the diet could restore this imbalance and mitigate its harmful effects on cardiovascular diseases. Many mechanisms are involved and included: (1) a reduction of bacteria producing trimethylamine (TMA); (2) an increase in bacteria producing butyrate, which has anti-inflammatory properties; and (3) a decrease in the production of pro-inflammatory cytokines. Additionally, omega-3 PUFAs would help maintain better integrity in the intestinal barrier, thereby preventing the translocation of intestinal contents into circulation. This review will summarize the effects of omega-3 PUFAs on gut micro-biota and the potential impact on cardiac health.

Citing Articles

Critical Review of the Cross-Links Between Dietary Components, the Gut Microbiome, and Depression.

Randeni N, Xu B Int J Mol Sci. 2025; 26(2).

PMID: 39859327 PMC: 11765984. DOI: 10.3390/ijms26020614.

Angiogenesis, a key point in the association of gut microbiota and its metabolites with disease.

Wang Y, Bai M, Peng Q, Li L, Tian F, Guo Y Eur J Med Res. 2024; 29(1):614.

PMID: 39710789 PMC: 11664877. DOI: 10.1186/s40001-024-02224-5.

Omega-3 nanoemulgel in prevention of radiation-induced oral mucositis and its associated effect on microbiome: a randomized clinical trial.

Morsy B, El Domiaty S, Meheissen M, A Heikal L, Meheissen M, Aly N BMC Oral Health. 2023; 23(1):612.

PMID: 37648997 PMC: 10470147. DOI: 10.1186/s12903-023-03276-5.

Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship.

Nesci A, Carnuccio C, Ruggieri V, DAlessandro A, Di Giorgio A, Santoro L Int J Mol Sci. 2023; 24(10).

PMID: 37240434 PMC: 10219307. DOI: 10.3390/ijms24109087.

Sodium butyrate in both prevention and supportive treatment of colorectal cancer.

Kazmierczak-Siedlecka K, Marano L, Merola E, Roviello F, Polom K Front Cell Infect Microbiol. 2022; 12:1023806.

PMID: 36389140 PMC: 9643746. DOI: 10.3389/fcimb.2022.1023806.

References

Kelly J, Kennedy P, Cryan J, Dinan T, Clarke G, Hyland N . Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015; 9:392. PMC: 4604320. DOI: 10.3389/fncel.2015.00392. View

Wu G, Chen J, Hoffmann C, Bittinger K, Chen Y, Keilbaugh S . Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011; 334(6052):105-8. PMC: 3368382. DOI: 10.1126/science.1208344. View

Rigottier-Gois L . Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis. ISME J. 2013; 7(7):1256-61. PMC: 3695303. DOI: 10.1038/ismej.2013.80. View

Bier A, Khasbab R, Haberman Y, Braun T, Hadar R, Sosnovski K . Antibiotic Treatment Does Not Ameliorate the Metabolic Changes in Rats Presenting Dysbiosis After Consuming a High Fructose Diet. Nutrients. 2020; 12(1). PMC: 7019627. DOI: 10.3390/nu12010203. View

Tan J, McKenzie C, Potamitis M, Thorburn A, Mackay C, Macia L . The role of short-chain fatty acids in health and disease. Adv Immunol. 2014; 121:91-119. DOI: 10.1016/B978-0-12-800100-4.00003-9. View

Elce A, Amato F, Zarrilli F, Calignano A, Troncone R, Castaldo G . Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells. Benef Microbes. 2017; 8(5):841-847. DOI: 10.3920/BM2016.0197. View

Riviere A, Selak M, Lantin D, Leroy F, De Vuyst L . Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut. Front Microbiol. 2016; 7:979. PMC: 4923077. DOI: 10.3389/fmicb.2016.00979. View

Chang P, Hao L, Offermanns S, Medzhitov R . The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2014; 111(6):2247-52. PMC: 3926023. DOI: 10.1073/pnas.1322269111. View

Krack A, Richartz B, Gastmann A, Greim K, Lotze U, Anker S . Studies on intragastric PCO2 at rest and during exercise as a marker of intestinal perfusion in patients with chronic heart failure. Eur J Heart Fail. 2004; 6(4):403-7. DOI: 10.1016/j.ejheart.2004.03.002. View

10.

Dinan T, Cryan J . The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterol Clin North Am. 2017; 46(1):77-89. DOI: 10.1016/j.gtc.2016.09.007. View

11.

Rondeau I, Picard S, Bah T, Roy L, Godbout R, Rousseau G . Effects of different dietary ω-6/3 polyunsaturated fatty acids ratios on infarct size and the limbic system after myocardial infarction. Can J Physiol Pharmacol. 2011; 89(3):169-76. DOI: 10.1139/Y11-007. View

12.

Uitterdijk A, Yetgin T, Te Lintel Hekkert M, Sneep S, Krabbendam-Peters I, van Beusekom H . Vagal nerve stimulation started just prior to reperfusion limits infarct size and no-reflow. Basic Res Cardiol. 2015; 110(5):508. PMC: 4549380. DOI: 10.1007/s00395-015-0508-3. View

13.

Turnbaugh P, Ley R, Mahowald M, Magrini V, Mardis E, Gordon J . An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027-31. DOI: 10.1038/nature05414. View

14.

Savage D . Associations of indigenous microorganisms with gastrointestinal mucosal epithelia. Am J Clin Nutr. 1970; 23(11):1495-501. DOI: 10.1093/ajcn/23.11.1495. View

15.

Dorfel M, Huber O . Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. J Biomed Biotechnol. 2012; 2012:807356. PMC: 3270569. DOI: 10.1155/2012/807356. View

16.

Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H . Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A. 2008; 105(6):2117-22. PMC: 2538887. DOI: 10.1073/pnas.0712038105. View

17.

Cario E, Gerken G, Podolsky D . Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology. 2004; 127(1):224-38. DOI: 10.1053/j.gastro.2004.04.015. View

18.

La Rosa S, Leth M, Michalak L, Hansen M, Pudlo N, Glowacki R . The human gut Firmicute Roseburia intestinalis is a primary degrader of dietary β-mannans. Nat Commun. 2019; 10(1):905. PMC: 6385246. DOI: 10.1038/s41467-019-08812-y. View

19.

Troseid M, Hov J, Nestvold T, Thoresen H, Berge R, Svardal A . Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery. Metab Syndr Relat Disord. 2016; 14(4):197-201. PMC: 4841908. DOI: 10.1089/met.2015.0120. View

20.

Yang B, Saldeen T, Bryant J, Nichols W, Mehta J . Long-term dietary fish oil supplementation protects against ischemia-reperfusion-induced myocardial dysfunction in isolated rat hearts. Am Heart J. 1993; 126(6):1287-92. DOI: 10.1016/0002-8703(93)90524-d. View